U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442526) titled 'AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients' on Feb. 24.
Brief Summary: The study compares an interventional strategy (PCI) with optimal medical therapy (OMT) in ultra-octogenarians with chronic total occlusions (CTO).
Results suggest that successful PCI leads to significant improvements in symptoms and quality of life compared to OMT alone. While initially carrying higher procedural risks, CTO-PCI is considered feasible and safe in experienced centers. There is also potential for long-term benefits in survival and a reduction in major adverse cardiovascular events (MACE). The choice between t...